The Year in Review 2024

Connecting the dots Connecting the dots Think U.S.A. Think U.S.A. Unveiling the Invisible Unveiling the Invisible Shaping Progress in the Drug Development Industry Shaping Progress in the Drug Development Industry Talita Conte Talita Conte Sophie Dubois Sophie Dubois Dr. Gaetano Morelli Dr. Gaetano Morelli CIBC Run for the Cure Course des Pompiers Reuters Insights Care - Altasciences Life Sciences Review Insights Care - Dr. Gaetano Morelli Mastera Mastera Hoth Therapeutics Hoth Therapeutics Altasciences CNS-Active Compounds Nonclinical AAV Gene Therapy Development Clinical Immunogenicity Studies Ligand Binding Assays Germline Integration Assessment Clinical Pathology Reference Data More - On-Demand Webinars More - Scientific Publications Nonclinical AAV Gene Therapy Development Starting First-in-Human Clinical Trials More - eBooks Sparking the Evolution of Microsampling with the Mitra® VAMS® Device Strategic Site Identification: A Proven Approach Collaborative Innovation: The Role of CROs and CDMOs in Shaping the Future of Drug Development More - Podcasts The Altascientist Issue No. 38 The Altascientist Issue No. 39 The Altascientist Issue No. 40 The Altascientist Issue No. 41 More - The Altascientist 4 Essential Topics to Cover in Your First CRO Meeting Pharmacokinetics, Pharmacodynamics, and Toxicokinetics Demystified How Improving Diversity Can Benefit Clinical Trials How Biotech Companies and CROs Can Better Align to Accelerate Development for the Most Promising Discoveries The Golden Era of GLP-1 Drugs: Where We Are and What Comes Next More - Articles Innovative Nanosuspension Approach to Maximize API Potency in Preclinical Formulation Development How to Evaluate Human Abuse Potential (HAP) for CNS Drugs More - Case Studies Webinar - The Golden Era of GLP-1 Drugs with Dr. Gaetano Morelli and Chad Rathlef The Altascientist Issue. 42 - Managing the Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development Case Study—GLP-1 RA: Rapid Clinical Phase I Study Execution Case Study - GLP-1 RA: Overcoming Known Pharmacological Effects Webinar - The Golden Era of GLP-1 Drugs with Dr. Gaetano Morelli and Chad Rathlef The Altascientist Issue. 42 - Managing the Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development Case Study—GLP-1 RA: Rapid Clinical Phase I Study Execution Case Study - GLP-1 RA: Overcoming Known Pharmacological Effects True Meaning of Moving in Unison Compass: Altasciences’ Proprietary Scheduling System Successful Project Case Study Advantages of Being a Mid-Sized CRO Seamless Communication and Collaboration Why Integration Matters Integrated Clinical and Manufacturing Expertise Examples of Clinic and CDMO Collaboration to Meet Your Needs The Importance of Geographic Location A Truly Integrated CRO and CDMO Video Conclusion Video Conclusion

Continue Reading

Highlights From the 2025 Society of Toxicology 64th Annual Meeting With Dr. Marianna Bacellar-Galdino, DVM, MSc, PhD
Case Study: How Altasciences Overcame Pharmacological Challenges in a GLP-1 IND-Enabling Study
Best Practices for Preclinical Dose Range Finding Studies
Inside Preclinical Ocular Research: With Dr. Simone Iwabe, DVM, PhD, DACVO, and Randy Wheeland, BS

2025 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy